Document is current
Any future updates will be listed below
-
Authors
Choi, Woo Jin
Ivanics, Tommy
Gravely, Annabel
Gallinger, Steven
Sapisochin, Gonzalo
O’Kane, Grainne M.
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 9 January 2023
First Online: 20 February 2023
Disclosure
: Grainne O’Kane discloses—Honoraria: Eisai, Roche, AstraZeneca; Consulting or Advisory Role: Eisai, Roche, AstraZeneca Canada, Incyte; Travel, Accommodations, Expenses: AstraZeneca/MedImmune. Gonzalo Sapisochin discloses consultancy for Astra-Zeneca, Roche, Novartis, Evidera, and Integra. Gonzalo Sapisochin has received financial compensation for talks for Roche, Astrazeneca, Chiesi, and Integra. Gonzalo Sapisochin has received a grant from Roche. None of the other authors have any conflict of interest to declare.
